The Human Cancer PrimaCell™ 3: Bladder Tumor Cells is for rapid (7-10 days) isolation and growth of human bladder tumor cells from human bladder tumor tissues. This system features an optimal condition of tissue dissociation system, Cancer OptiTDS™ that yields 5-7 times of single cells more than most of the tissue dissociation protocols published in the literature. In addition, this system ensures a high viability of the target cells with improved gradient contained in the culture medium.

Human Cancer PrimaCell™ 3 System (Cat No. 2-96026):
Human Cancer PrimaCell™ 3: Bladder Tumor Cells Protocols
Human Cancer Tissue Preparation Buffer 3: Bladder Tumor Cells
Human Cancer OptiTDS™ 3: Tissue Dissociation System
Human Cancer PrimaCell™ 3: Bladder Tumor Cells Growth Medium
Human Cancer PrimaCell™ 3: Bladder Tumor Cells Growth Supplements with Serum (for 500 ml medium)

References:

[1] Bentivegna A, Conconi D, Panzeri E, Sala E, Bovo G, Viganò P, Brunelli S, Bossi M, Tredici G, Strada G, Dalprà L. Biological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samples. Cancer Sci. 2010 Feb;101(2):416-24. Epub 2009 Oct 27.
[2] Cunderlíková B, Wahlqvist R, Berner A, Vasovic V, Warloe T, Nesland JM, Peng Q. Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples. Cytopathology. 2007 Apr;18(2):87-95.